发明名称 |
TEM8 antibodies, conjugates thereof, and their use |
摘要 |
Antibodies that specifically bind TEM8 protein, and conjugates thereof, are disclosed herein. In some examples the conjugates and antibodies are useful for methods of detecting and treating pathogenic angiogenesis. In other examples the conjugates and antibodies are useful for methods of detecting and treating cancer. In additional examples, the conjugates and antibodies are useful for methods of decreasing binding of Anthrax protective antigen to a cell. |
申请公布号 |
US9181340(B2) |
申请公布日期 |
2015.11.10 |
申请号 |
US201214126372 |
申请日期 |
2012.06.13 |
申请人 |
The United States of America, as represented by the Secretary, Department of Health and Human Services;Novartis AG |
发明人 |
St. Croix Brad;Fleming Tony;Chaudhary Amit;Saha Saurabh;Zhang Xiaoyan Michelle;Kwong Rou-fun;Hilton Mary Beth |
分类号 |
C07K16/30;C07K16/28;A61K39/00 |
主分类号 |
C07K16/30 |
代理机构 |
Klarquist Sparkman, LLP |
代理人 |
Klarquist Sparkman, LLP |
主权项 |
1. An isolated monoclonal antibody or antigen binding fragment thereof, comprising a heavy chain variable region comprising a heavy chain complementarity determining region (HCDR)1, a HCDR2, and a HCDR3, and a light chain variable region comprising a light chain complementarity determining region (LCDR)1, a LCDR2, and a L-CDR3, of the amino acid sequences set forth as one of:
(a) SEQ ID NO: 1 and SEQ ID NO: 6, respectively (L2); (b) SEQ ID NO: 2 and SEQ ID NO: 7, respectively (L1); (c) SEQ ID NO: 3 and SEQ ID NO: 8, respectively (L3); (d) SEQ ID NO: 4 and SEQ ID NO: 9, respectively (L5); or (e) SEQ ID NO: 5 and SEQ ID NO: 10, respectively (1D2); and wherein the monoclonal antibody or antigen binding fragment specifically binds to TEM8. |
地址 |
Washington DC US |